Determinants of Mortality among HIV Positives after Initiating Antiretroviral Therapy in Western Ethiopia: A Hospital-Based Retrospective Cohort Study.

ISRN AIDS Pub Date : 2013-02-20 eCollection Date: 2013-01-01 DOI:10.1155/2013/491601
Mitiku Teshome Hambisa, Ahmed Ali, Yadeta Dessie
{"title":"Determinants of Mortality among HIV Positives after Initiating Antiretroviral Therapy in Western Ethiopia: A Hospital-Based Retrospective Cohort Study.","authors":"Mitiku Teshome Hambisa,&nbsp;Ahmed Ali,&nbsp;Yadeta Dessie","doi":"10.1155/2013/491601","DOIUrl":null,"url":null,"abstract":"<p><p>Studies revealed that there are various determinants of mortality among HIV positives after ART initiation. These determinants are so variable with context and dynamic across time with the advancement of cares and treatments. In this study we tried to identify determinants of mortality among HIV positives after initiating ART. A retrospective cohort study was conducted among 416 ART attendees enrolled between July 2005 to January 2012 in Nekemte Referral Hospital, Western Ethiopia. Actuarial table was used to estimate survival of patients after ART initiation and log rank test was used to compare the survival curves. Cox proportional-hazard regression was applied to determine the independent determinants of time to death. The estimated mortality was 4%, 5%, 6%, 7%, and 7% at 6, 12, 24, 36 and 48 months respectively with mortality incidence density of 1.89 deaths per 100 person years (95% CI 1.74, 3.62). Forty years and above AHR = 3.055 (95% CI 1.292, 7.223), low baseline hemoglobin level (AHR = 0.523 (95% CI .335, 0.816)), and poor ART adherence (AHR 27.848 (95% CI 8.928, 86.8)) were found to be an independent determinants of mortality. These determinants of mortality have to be taken into account to enhance better clinical outcomes of ART attendees. </p>","PeriodicalId":89950,"journal":{"name":"ISRN AIDS","volume":"2013 ","pages":"491601"},"PeriodicalIF":0.0000,"publicationDate":"2013-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/491601","citationCount":"37","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN AIDS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2013/491601","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2013/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 37

Abstract

Studies revealed that there are various determinants of mortality among HIV positives after ART initiation. These determinants are so variable with context and dynamic across time with the advancement of cares and treatments. In this study we tried to identify determinants of mortality among HIV positives after initiating ART. A retrospective cohort study was conducted among 416 ART attendees enrolled between July 2005 to January 2012 in Nekemte Referral Hospital, Western Ethiopia. Actuarial table was used to estimate survival of patients after ART initiation and log rank test was used to compare the survival curves. Cox proportional-hazard regression was applied to determine the independent determinants of time to death. The estimated mortality was 4%, 5%, 6%, 7%, and 7% at 6, 12, 24, 36 and 48 months respectively with mortality incidence density of 1.89 deaths per 100 person years (95% CI 1.74, 3.62). Forty years and above AHR = 3.055 (95% CI 1.292, 7.223), low baseline hemoglobin level (AHR = 0.523 (95% CI .335, 0.816)), and poor ART adherence (AHR 27.848 (95% CI 8.928, 86.8)) were found to be an independent determinants of mortality. These determinants of mortality have to be taken into account to enhance better clinical outcomes of ART attendees.

Abstract Image

Abstract Image

在埃塞俄比亚西部开始抗逆转录病毒治疗后HIV阳性患者死亡率的决定因素:一项基于医院的回顾性队列研究。
研究表明,在开始抗逆转录病毒治疗后,艾滋病毒阳性者的死亡率有各种决定因素。这些决定因素随着环境的变化而变化,随着护理和治疗的进步而变化。在这项研究中,我们试图确定艾滋病毒阳性患者在开始抗逆转录病毒治疗后死亡的决定因素。对2005年7月至2012年1月在埃塞俄比亚西部Nekemte转诊医院登记的416名抗逆转录病毒治疗参与者进行了一项回顾性队列研究。采用精算表估计ART开始后患者的生存,采用log rank检验比较生存曲线。采用Cox比例风险回归来确定死亡时间的独立决定因素。6、12、24、36和48个月时的估计死亡率分别为4%、5%、6%、7%和7%,死亡率发病率密度为每100人年1.89例死亡(95% CI 1.74, 3.62)。40岁及以上的AHR = 3.055 (95% CI 1.292, 7.223),低基线血红蛋白水平(AHR = 0.523 (95% CI .335, 0.816))和不良ART依从性(AHR 27.848 (95% CI 8.928, 86.8))被发现是死亡率的独立决定因素。必须考虑到这些死亡率决定因素,以提高抗逆转录病毒治疗参与者的更好临床结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信